No Data
Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth
Rodman & Renshaw Initiates Nkarta(NKTX.US) With Buy Rating, Announces Target Price $14
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
Insiders Who Sold Nkarta Missed Out On 15% Stock Increase
Nkarta to Participate in Upcoming Investor Conference
Mizuho Securities Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $20
Mizuho Securities analyst Salim Syed maintains $Nkarta(NKTX.US)$ with a buy rating, and adjusts the target price from $25 to $20.According to TipRanks data, the analyst has a success rate of 39.0%
No Data
No Data